Fairfax, Va. (March 6, 2019) — Virginia Cancer Specialists (VCS) is pleased to announce that Sandeep J. Khandhar, MD, FACS, a thoracic surgeon, has joined the practice. Dr. Khandhar has extensive experience in minimally invasive procedures, bringing new surgical expertise to VCS and enhancing the practice’s multidisciplinary lung cancer team. VCS, a practice in The US Oncology Network, is a premier cancer care and research center in Northern Virginia with more than 40 years of service to patients.
“The complexity of lung diseases requires a multidisciplinary team approach to better manage the comprehensive care required to drive optimal outcomes,” said Alex Spira, MD, PhD, FACP, medical oncologist and lung cancer specialist at VCS and co-chair of The US Oncology Network Thoracic Oncology Committee. “Dr. Khandhar is highly skilled in the very latest minimally invasive surgical techniques that provide a better postoperative experience for patients. His surgical expertise is a great addition to our lung cancer team, and we look forward to seeing many contributions from him that will enhance patient care.”
Board certified in cardiothoracic surgery and general surgery, Dr. Khandhar has more than 20 years of clinical experience. He earned a degree from Northwestern University in Biomedical Engineering followed by his medical degree. He then went on to complete his internship and residency in General Surgery at the University of Texas Health Science Center at San Antonio, where he also served as the administrative chief resident. There he completed a fellowship in Cardiothoracic Surgery and further specialized in Thoracic Surgery and Thoracic Oncology at Duke University. He has been practicing cardiothoracic surgery in Northern Virginia for over a decade. During that time, he has received many awards and honors, including being named to Northern Virginia Magazine’s Top Doctors and Washingtonian’s Top Doctors.
“Dr. Khandhar is a highly-respected leader in his field, and he will play a key role in helping us achieve improved outcomes for our lung cancer patients,” said Gregory Sibley, MD, VCS radiation oncologist. “He has extensive training in all of the exciting new surgical techniques that are providing a better quality of life and improved outcomes to patients. We are honored to have him join our team.”
Dr. Khandhar has served in many hospital leadership roles, and he continues in this capacity. In an effort to steer the direction of growth and development in surgical lung cancer treatment, he sits on the advisory boards of leading medical device companies global-wide, keeping them abreast of cutting-edge technological innovations in the thoracic field.
“When highly-skilled like-minded individuals come together to care for patients, more effective treatment and a better patient experience are possible, leading to optimal quality of life and longevity,” said Dr. Khandhar. “I am excited to join the world-class VCS lung cancer team, as they share my philosophy of collaboration to obtain the best results for patients.”
The Virginia Cancer Specialists multidisciplinary lung cancer team includes thoracic surgeons, medical oncologists, radiation oncologists and other cancer specialists who are on the cutting-edge of lung cancer treatment and care. VCS, which is the region’s leading research facility, also offers numerous novel clinical trials for lung cancer, enabling patients to have convenient access to promising new therapies close to home.
About Virginia Cancer Specialists
Virginia Cancer Specialists (VCS) has built a practice with a world-class treatment team fighting cancer and diseases of the blood, offering access to the most current treatment protocols, clinical trials, and comprehensive care all available in a community-based setting. With nine locations throughout Northern Virginia, staffed by more than 30 highly-skilled physicians, VCS delivers specialized, exceptional care. Virginia Cancer Specialists offers medical oncology, radiation oncology, musculoskeletal tumor surgery, breast surgery, thoracic surgery, genetic counseling, oncology nurse navigators, oncology infusion nurses, oncology pharmacists and laboratory technicians. Our multidisciplinary team works together to design the optimal treatment program, efficiently sharing knowledge, and providing a patient-centered, consumer-friendly approach to cancer care. Patients receive a 360-degree full spectrum of high-quality care from a care team united in their effort to provide each patient with the personalized care they need to battle cancer.
Virginia Cancer Specialists has a well-established, fully staffed, comprehensive clinical research program with a dedicated research facility for phase 1 clinical trials – the largest of its kind in the Northern Virginia area. The practice has access to hundreds of innovative clinical trials through its affiliation with The US Oncology Network, one of the nation’s largest associations of community-based oncologists and a leader in the advancement of cancer research and treatment. The US Oncology Network conducts clinical research through US Oncology Research, which has played a role in approximately one-third of all FDA approvals for cancer therapies. US Oncology Research manages about 300 active trials at any given time, with VCS participating in many of them, testing new leading-edge drugs or various combinations of treatments for cancer and blood disorders. To learn more about Virginia Cancer Specialists, please visit www.VirginiaCancerSpecialists.com.